Avanzanite Bioscience Launches Novel Business Model to Comme

Establishes first-in-class biopharmaceutical commercialization platform specifically addressing rare diseases in Europe Secured exclusive rights in 26 European Countries to an investigational

Related Keywords

Italy , Canada , Switzerland , Kostenloser Wertpapierhandel , Adam Plich , Avanzanite Bioscience , Adam Andrzej Plich , Leopoldo Zambeletti , Anant Murthy , European Medicines Agency , Teva Pharmaceuticals , Board Advisor , Advisory Board , Business Wire , Acanthamoeba Keratitis , European Economic Area , Fabrizio Chines , Vice President , General Manager , Dawn Sherman , European Economic , Avanzanite , Ioscience , Aunches , Novel , Business , Model , Ommercialize , Nnovative , Medicines , Mare , Diseases , Europe ,